DilenyTech

16/03/2022

We are excited to start a new chapter of AI innovation with Astute Imaging.

The Acquisition Will Enable Astute Imaging to Expedite the Development of an AI Driven image-guided Therapy Platform Kirkland, WA – March 15, 2022 - Astute Imaging LLC, a provider of imaging-guided therapy and procedure planning services, announced the acquisition of Dileny Technologies (DilenyTec...

08/02/2022

More towards innovation and validation for DilenyTech's AI technologies with Medical partners.

In a recent clinical study, our ultrasound AI-enabled elastography software US-Elasto© was used to compare the elasticity of different breast masses using conventional ultrasound images. The study was performed by notable researchers at Cairo University School of Medicine and published in the Egyptian Journal of Radiology and Nuclear Medicine.

US-Elasto AI technology was granted a patented from the United States Patent and Trademark Office in 2021.
For research details: https://link.springer.com/article/10.1186/s43055-022-00703-5

Background Conventional ultrasound elastography is a relatively novel noninvasive imaging study that assesses tissue stiffness and helps in the characterization of breast lesions. However, strain elastography is not available in some ultrasound machines especially those before 2003 and is susceptibl...

20/01/2022

Too many mammography exams to read, and you need artificial intelligence to help!
No worries... MammoSUGGEST AI can help radiology consultants to read, localize, and/or classify different breast abnormalities in mammograms in less than 10 seconds.
MammoSUGGEST is a US registered trademark. The AI program is available as cloud-based or on-premises software.
MammoSUGGEST AI has been tested and trained using +1 million mammography patches in collaboration with TOP-tier medical organizations.
Free trials available for medical organization. Request now

19/01/2022

Another fruit of the long-term and wonderful collaboration between Women And Fetal Imaging مركز وافي للأشعة and DilenyTech in breast imaging!
We are glad to announce that another research is accepted at the European Congress of Radiology ECR 2022. The work addresses a state-of-the-art topic in breast imaging entitled "Two view low dose digital mammography combined with a single view wide-angle digital breast tomosynthesis versus full-field digital mammography; impact on the glandular dose and clinic performance"
Thank you WAFI team led by Prof. Hanan Gewefel and Dr. Iman Ewais for this opportunity to work with you.

10/01/2022

DilenyTech is glad to share the acceptance of our abstract in the No. 1 radiology conference in Europe ECR 2022 in collaboration with Baheya Foundation - مؤسسة بهية for research.
A novel approach for AI in mammography entitled "Synthetic contrast-enhanced mammography without contrast injection: computer-aided breast mass classification system with new virtual technique"
A wonderful collaboration with the medical experts in Baheya Foundation, and many more to come!

03/01/2022

We were blessed in 2021 with great achievements at DilenyTech, and more good news to come in 2022!

We are pleased to start 2022 with the new achievements of our R&D team at Dilenytech in the field of AI and breast imaging!

DilenyTech has been part of two research abstracts that have been just accepted in the ECR 2022 meeting in collaboration with top medical researchers and organizations in the field of breast imaging.

DilenyTech has been selected as one of the most promising and growing AI healthcare startups.

Stay tuned for more news!

30/12/2021

Thousands of screening mammography recalls are taking place worldwide everyday!
A second-reader radiologist can be a solution, BUT there is a worldwide shortage in radiologists.
DilenyTech is providing innovative AI-Enabled solutions for breast consultants and radiologists.
We will help you to make your breast workflow smarter, and more efficient and productive.
Using our innovative AI, not only you can automatically prioritize reading scans according to radiological findings, but you can prioritize patients' visits.
Request a demo to learn more about our AI-Enabled solution

26/12/2021

DilenyTech is listed among the high-growth African Startups in Healthtech by dadupa,

13/12/2021

Combining AI and cloud computing achieves a more precise medicine.
Cloud-based MammoSUGGEST AI aims to democratize precision medicine.
MammoSUGGEST AI helps to avoid overlooking breast abnormalities in mammograms.
MammoSUGGEST AI can be integrated with a breast risk assessment to prioritize patients’ visits.
Automated AI reports are generated, where breast abnormalities such as masses and calcifications are classified and highlighted.
Book your demo session to learn more about different options.

29/11/2021

Get the 5 benefits when adopting MammoSUGGEST AI:
1- A second eye on mammograms via AI technologies
2- Automatic prioritization for mammography studies for reading
3- AI-enabled detection and localization of abnormalities in mammograms
4- Automatic AI multi-media reports
5- Up to 30% increase in study processing efficiency.

To learn more about the benefits of MammoSUGGEST AI, request a demo now.

11/11/2021

Complement your decision with AI, improve your productivity, and streamline workflow with fewer clicks.
MammoSUGGEST AI desktop application detects and highlights abnormalities including calcifications and masses within mammograms.
Support your decision on mammography studies with MammoSUGGEST AI and enjoy other helpful tools.
Don’t hesitate to contact us and get your free trial for the MammoSUGGEST desktop application.

04/11/2021

Don't miss NVIDIA 's interesting session
"Accelerating Med Tech Deployment in Emerging Markets"
with Dr. Ahmed Ehab A. Mahmoud, Founder, and chief innovation officer of DilenyTech
Tuesday, Nov 9 | 4:00 PM EET
Register now: https://www.nvidia.com/gtc/